Dr. Todd Adam Gersten, MD

Dr. Gersten practices at Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare.

Dr. Gersten's NPI, 1962408047, was assigned on June 23, 2005. Dr. Gersten graduated from Rutgers Robert Wood Johnson Medical School in 1997. Dr. Gersten holds Florida license ME83684.

Dr. Gersten's primary practice is Good Samaritan Medical Center, at 1309 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 655-5511.

Dr. Gersten's primary practice is Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare. Dr. Gersten is also affiliated with HCA Florida JFK Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Gersten to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gersten practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Gersten's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Gersten is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Gersten's licenses on file in 2 states: Florida and South Carolina.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Gersten treats.

CMS data shows 54,716 Medicare services from Dr. Gersten across 48 procedure codes in 2024, for 812 Medicare patients. Medicare paid $1,077,823 for them.

CMS counts 812 Medicare patients who saw Dr. Gersten in 2024. The largest group is 75 to 84, with 317 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gersten's median patient age at 62, with 66% women.

In 2024, Dr. Gersten wrote 1,526 Medicare Part D claims for 243 patients. 72% of them were for generic drugs. CMS names the drug for 1,205 of them, across 41 drugs with 11 or more claims each, at $4,176,578 in total drug cost. In 2023, CMS named 904 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gersten for performance year 2024, reported as part of a group. Dr. Gersten accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Gersten in 2021. Dr. Gersten's most frequent co-authors are J Thaddeus Beck, FACP, MD, Maen A. Hussein, MD and Keith A. Lerro, MD.

Dmand AI links Dr. Gersten to 12 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Rectal Diseases. Eli Lilly and Company sponsors the most, 2.

CMS Open Payments shows 2,590 general payments to Dr. Gersten from 104 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Amgen Inc. paid the most, $10,607.

Dmand AI lists 1 award for Dr. Gersten, most recently CMS Stage 1 EHR in 2014.

Dr. Gersten graduated from Rutgers Robert Wood Johnson Medical School in 1997. Dr. Gersten is a member of ASCO and ASH.

Dr. Gersten is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.